Factor XIII in ulcerative leg disease: Background and preliminary clinical results

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 5, 1996, Pages 445-450

  Wozniak, Gernold ^a   Dapper, Friedhelm ^a   Alemany, José ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Knappschafts Krankenhaus   (Germany)

Author keywords

epithelialization; granulation; postthrombotic syndrome; secretion; topical application

Indexed keywords

BLOOD CLOTTING FACTOR 13 CONCENTRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EPITHELIZATION; FEMALE; HUMAN; LEG; MALE; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; ULCER; ULCER HEALING; WOUND HEALING;

EID: 0030466703     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-999044     Document Type: Article

References (43)

1. Forrest RD: Early history of wound treatment. Development of wound therapy from the Dark Ages to the present. J R Soc Med 75:198-273, 1982.
2. Cremer H: Zur Behandlung typischer Alltagswunden. Extract Med Practica 5(suppl 1):21-23, 1984.
3. Fajardo LF, M Berthrong: Radiation injury in surgical pathology. Part I. Am J Surg Pathol 2:159-199, 1978.
4. Kitahama A, LF Elliott, MD Kerstein, CV Menendez: Leg ulcer. Conservative management or surgical treatment? JAMA 247:197-199, 1982.
5. Sinacore DR, MJ Mueller, JE Diamond, VP Blair 3d, D Drury: Diabetic plantar ulcers treated by total contact casting. A clinical report. Phys Ther 67:1543-1549, 1987.
6. Pieber TR, S Schattenberg, B Möstl, GA Brunner, J Plank, GJ Krejs: Treatment of non-healing neuropathic ulcers in the diabetic foot syndrome with factor XIII. Blood Coagul Fibrinol 6:349-350, 1995.
7. Knapp U: Allgemeine und lokale Störfaktoren der Wundheilung. Extract Med Practica 5(suppl 1):25-34, 1984.
8. Wozniak G, H Montag, J Alemany: Local therapy of chronic venous ulceration with factor XIII: First clinical assessment. Ann Hematol 68(suppl II):130, 1994.
9. Wozniak G, H Montag, J Alemany: Lokalapplikation von F XIII zur Therapie kruraler Ulcerationen bei Patienten mit postthrombotischer Anamnese. Vasomed 5:644-651, 1993.
10. Klüken N, M Zabel: Anatomie pathologique de l'atrophie blanche. Phlébologie 39:561-566, 1986.
11. Zabel M, H Hettwer: Zur Pathogenese der Atrophie blanche - histologische und elektronenmikroskopische Untersuchungen. Phlebol Proktol 16:23-26, 1987.
12. Burnand KG, I Whimster, A Naidoo, NL Browse: Pericapillary fibrin in the ulcer-bearing skin of the leg: The cause of lipodermatosclerosis and venous ulceration. Br Med J 285:1071-1073, 1982.
13. Browse NL, KG Burnand: The cause of venous ulceration. Lancet 11:243-245, 1982.
14. Coleridge Smith PD, P Thomas, JH Scurr, JA Dormandy: Causes of venous ulceration: A new hypothesis. Br Med J Clin Res Ed 296:1726-1727, 1988.
15. Cornwall JV, CJ Dore, JD Lewis: Leg ulcers: Epidemiology and aetiology. Br J Surg 73:693-696, 1986.
16. Van der Molen HR: Über die chronisch venöse Insuffizienz. In: Van der Molen HR (Ed): Verhandlungen der Deutschen Gemeinschaft für Venenerkrankungen. Schattauer, Stuttgart. Germany, 1957, pp 41-59.
17. Bolliger A: Konservative Therapie der chronisch venösen Insuffizienz. In: Klüken N (Ed): Die akute und chronisch venöse Insuffizienz. Schattauer, Stuttgart, Germany, 1990, pp 262-267.
18. Rabe E: Zur Pathogenese der chronisch venösen Insuffizienz. In: Klüken N (Ed): Die akute und chronisch venöse Insuffizienz. Schattauer, Stuttgart, Germany, 1990, pp 153-163.
19. Shami SK, S Sarin, TR Cheatle, JH Scurr, PD Coleridge Smith: Venous ulcers and the superficial venous system. J Vasc Surg 17: 487-490, 1993.
20. Falanga V, H Moosa, AJ Nemeth, SP Alstadt, WH Eaglestein: Dermal pericapillary fibrin in venous disease and venous ulceration. Arch Dermatol 123:620-623, 1987.
21. Payé M, ChM Lapière: Wundheilung: Der Beitrag des Gerinnungsfaktor XIII. Die gelben Hefte 26:128-135, 1986.
22. Klüken N, M Zabel: La pigmentation est-elle un signe caractéristique de l'insuffisance veineuse chronique. Phlébologie 36:315-320, 1983.
23. Wolfe JH, M Morland, NL Browse: The fibrinolytic activity of varicose veins. Br J Surg 66:185-187, 1979.
24. Baer U, J Bauknecht, Th Stangl, R Häring: Verminderung von Wundheilungsstörungen durch prä- und postoperative quantitative Faktor-XIII-Substitution. Zbl Chirurgie 105:642-651, 1980.
25. Marktl W, B Rudes: The effect of F XIII on wound granulation in the rat. Thromb Diath Haemorrh 32:578-581, 1974.
26. Vanscheidt W, K Halser, H Wokalek, R Niedner, E Schöpf: Factor XIII-deficiency in the blood of venous leg ulcer patients. Acta Dermatol Venerol 71:55-57, 1991.
27. Wokalek H, R Niedner: Enzymatische Wundreinigung. Extract Med Practica 5(suppl 1):35-42, 1984.
28. Rodeheaver G, D Marsh, MT Edgerton, RF Edlich: Proteolytic enzymes as adjuncts to antimicrobial prophylaxis of contaminated wounds. Am J Surg 129:537-544, 1975.
29. Fischer H, F Gilliet, M Hornemann, J Jost, F Leyh, H Lindenmayer, W Stegmann, S Velke: Enzymatische Wundreinigung beim Ulcus cruris. Extract Med Practica 5(suppl 1):69-73, 1984.
30. Wozniak G, H Akintürk, FW Hehrlein, J Alemany: Topical application of F XIII improves wound healing of ulcerative leg disease: Clinical experience. Blood Coagul Fibrinol 6:349, 1995.
31. McDonagh J: Biochemistry of fibrin-stabilizing factor (XIII). In: McDonagh J, R Seitz, R Egbring (Eds): Factor XIII. Schattauer, Stuttgart, Germany, 1993, pp 2-8.
32. Brown LF, N Lanir, J McDonagh, K Czarnecki, P Estrella, AM Dvorak, HF Dvorak: Fibroblast migration in fibrin gel matrices. J Cell Biol 114:346a, 1991.
33. Barry EL, DF Mosher: Factor XIII crosslinking of fibronectin at cellular matrix assembly sites. J Biol Chem 263:10464-10469, 1988.
34. Reed GL, GR Matsueda, E Haber: Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha2-antiplasmin to fibrin. Thromb Haemost 68:315-320, 1992.
35. Francis CW, VJ Marder: Increased resistance to plasmatic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations. Blood 71:1361-1365, 1988.
36. Uchino R, M Cardinali, SI Chung: Regulation of extravascular fibrinolysis by factor XIII. Fibrinolysis 5:93-98, 1991.
37. Lazarus GS, DM Cooper, DR Knighton, DJ Margolis, RE Pecoraro, G Rodeheaver, MC Robson: Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 130:489-493, 1994.
38. Brown GL, LB Nanney, J Griffen, AB Cramer, JM Yancey, LJ Curtsinger, L Holtzin, GS Schultz, MJ Jurkiewicz, JB Lynch: Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 321:111-112, 1989.
39. Knighton DR, K Ciresi, VD Fiegel, S Schumerth, E Butler, F Cerra: Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 170:56-60, 1990.
40. Spencer EM, G Skover, TK Hunt: Somatomedins: Do they play a pivotal role in wound healing? Proc Clin Biol Res 266:103-116, 1988.
41. Bucalo B, WH Eaglstein, V Falanga: The effect of chronic wound fluid on cell proliferation in vitro. J Invest Dermatol 92:408, 1989.
42. Backhouse CM, SD Blair, AP Savage, J Walton, CN McCollum: Controlled trial of occlusive dressings in healing chronic venous ulcers. Br J Surg 74:626-627, 1987.
43. Hirahara K, K Shinbo, M Takahashi, T Matsuishi: Suppressive effect of human blood coagulation factor XIII on the vascular permeability induced by anti-guinea pig endothelial cell antiserum in guinea pigs. Thromb Res 71:139-148, 1993.